Literature DB >> 33309269

Neuraminidase inhibitory diarylheptanoids from Alpinia officinarum: In vitro and molecular docking studies.

Guijae Yoo1, Jun Hyung Park2, Seung Hyun Kim3.   

Abstract

Diarylheptanoids, known to be rich in the Zingiberaceae family, have been reported to have various pharmacological activities including neuraminidase (NA) inhibitory activity. In this study, to analyze the correlation between NA and diarylheptanoid, A. officinarum, belonging to the Zingiberaceae family, was selected as a natural resource. Four new compounds along with 26 known diarylheptanoids from the rhizomes of A. officinarum were isolated using various chromatographic techniques. The Structure-based virtual screening (SBVS) was performed to discover putative binding ligand and corresponding binding conformation of the isolated compounds. Among the isolated compounds, 10 compounds showed stable binding energy levels in NA. Five of these 10 potential hits showed the potent inhibitory activity through in vitro NA enzyme assay. Moreover, it can be deduced that hydrogen-bonding formation between carbonyl group of active diarylheptanoids and arginine 555 and arginine 615 of NA allowed for the most stable binding between the enzyme and docked compounds.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpinia officinarum; Chemical profiling; Molecular docking; Neuraminidase inhibitor; Structure-based virtual screening

Year:  2020        PMID: 33309269     DOI: 10.1016/j.bioorg.2020.104526

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

Review 1.  Recent Advances in Application of Computer-Aided Drug Design in Anti-Influenza A Virus Drug Discovery.

Authors:  Dahai Yu; Linlin Wang; Ye Wang
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

Review 2.  The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases.

Authors:  Dignê Tembely; Aubéri Henry; Laetitia Vanalderwiert; Kevin Toussaint; Amar Bennasroune; Sébastien Blaise; Hervé Sartelet; Stéphane Jaisson; Céline Galés; Laurent Martiny; Laurent Duca; Béatrice Romier-Crouzet; Pascal Maurice
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-11       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.